Consolidated Balance Sheets - USD ($)	May 31, 2016	May 31, 2015
Current Assets:
Cash and cash equivalents	$ 10,263,000	$ 18,363,000
Accounts receivable, net	62,043,000	67,674,000
Inventories, net	46,894,000	41,847,000
Prepaid expenses and other current assets	8,479,000	11,161,000
Total current assets	127,679,000	139,045,000
Property and equipment, net	76,015,000	73,574,000
Goodwill	857,023,000	842,258,000
Other intangible assets, net	633,097,000	650,294,000
Other assets	13,819,000	15,167,000
Total assets	1,707,633,000	1,720,338,000
Current Liabilities:
Accounts payable	22,229,000	13,866,000
Accrued interest and interest rate swap liability	18,869,000	19,288,000
Accrued expenses and other current liabilities	22,009,000	26,132,000
Income taxes payable	2,585,000	3,496,000
Deferred revenue, current portion	2,864,000	2,703,000
Current portion of long-term debt	6,806,000	6,640,000
Total current liabilities	75,362,000	72,125,000
Long-term debt, excluding current portion	1,007,948,000	1,004,706,000
Deferred income tax liabilities	222,357,000	230,614,000
Other long-term liabilities	57,420,000	29,212,000
Total liabilities	1,363,087,000	1,336,657,000
Commitments and Contingencies (Note 24)
Equity:
Common stock, $0.00 par value, 100 shares authorized, issued and outstanding as of May 31, 2016 and May 31, 2015, respectively
Additional paid-in capital	753,709,000	755,234,000
Accumulated deficit	(374,079,000)	(331,989,000)
Accumulated other comprehensive loss	(39,407,000)	(39,564,000)
Total shareholders' equity of Immucor, Inc.	340,223,000	383,681,000
Noncontrolling interest	4,323,000
Total equity	344,546,000	383,681,000
Total liabilities and equity	$ 1,707,633,000	$ 1,720,338,000